SYSTM Wealth Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,771
Closed -$402K 455
2024
Q2
$402K Sell
3,771
-659
-15% -$66.2K 0.09% 154
2024
Q1
$436K Sell
4,430
-1,466
-25% -$150K 0.06% 297
2023
Q4
$595K Sell
5,896
-739
-11% -$71.3K 0.08% 252
2023
Q3
$676K Sell
6,635
-3,262
-33% -$331K 0.1% 236
2023
Q2
$999K Sell
9,897
-120
-1% -$12K 0.14% 198
2023
Q1
$922K Sell
10,017
-940
-9% -$82.1K 0.14% 188
2022
Q4
$994K Buy
+10,957
New +$923K 0.12% 211

Other funds holding NVS

SYSTM Wealth Solutions's NVS Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Novartis (NVS) in Q3 2024, closing a stake of 3,771 shares — an estimated $402K sold.

SYSTM Wealth Solutions first reported a position in NVS in Q4 2022 and held it in 7 quarters. The position peaked at $999K in Q2 2023. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 3,771 Novartis shares in Q3 2024, an estimated $402K.
  • SYSTM Wealth Solutions first reported a position in Novartis in Q4 2022 and held it in 7 quarters.
  • SYSTM Wealth Solutions's Novartis position peaked at $999K in Q2 2023.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.